Twi
Transaction Case Studies JAPAN COLLABORATION FOR A PHASE 2 ORPHAN DERMATOLOGY ASSET AC-203, A NOVEL TOPICAL TREATMENT FOR EPIDERMOLYSIS BULLOSA […]
Uncategorized
News
Garuda Therapeutics Launches with $72 Million Series A Financing
LOCUST WALK NEWS Garuda Therapeutics Launches with $72 Million Series A Financing CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics, a company creating off-the-shelf,
News
Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing
News
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company
News
Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1, 2021
LOCUST WALK NEWS Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1,
News
Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option
LOCUST WALK NEWS Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option PHILADELPHIA
Podcast
Biotalk Episode 15: 2024 Q1 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 11:03 — 25.3MB)
Subscribe: Apple Podcasts | Spotify | RSS
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Q1 Report: Global Trends in Biopharma Transactions Report. Each quarter,
Insight, Locust Walk Insights, Market Trends, Quarterly Reports
2024 Q1 Report: Global Trends in Biopharma Transactions
2024 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
Insight, Market Trends, Quarterly Reports
Overview of AI in Biotech
Overview of AI in Biotech Locust Walk’s Overview of AI in Biotech report discusses how AI has profoundly impacted drug
Uncategorized
Biotalk Episode 14: A Conversation with Kendalle Burlin O’Connell of MassBio
Podcast: Play in new window | Download (Duration: 35:36 — 81.5MB)
Subscribe: Apple Podcasts | Spotify | RSS
On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Kendalle Burlin O’Connell, Esq., CEO and President of MassBio, the nation’s pioneering biotechnology trade